Generic Name |
tocilizumab |
---|---|
Strength |
|
Form |
concentrate solution for intravenous (IV) infusion vials, solution in pre-filled syringes for subcutaneous (SC) injection, and autoinjector pen |
Special Authority Criteria |
Approval Period |
---|---|
For the treatment of rheumatoid arthritis (RA) when:
AND
|
First approval: 1 year Renewal: 1 year or indefinite |